April 30, 2024 at 09:26PM FDA Roundup: April 30, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/D21dr4h

April 30, 2024 at 04:04PM Blood Guidances

This page contains a listing of Blood Guidances guidances.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/k0drw1O

April 30, 2024 at 04:02PM Recognition and Use of a Standard for Uniform Blood and Blood Component Container Labels

We, FDA, Center for Biologics Evaluation and Research (CBER), are recognizing as acceptable for use by you, manufacturers of blood and blood components, subject to United States statutes and regulations, the document entitled “United States Industry Consensus Standard for the Uniform Labeling

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/dJU1Rmq

Thursday, April 25, 2024

April 26, 2024 at 12:07AM TECARTUS

For the treatment of adult patients with relapsed or refractory (r/r) B-cell precursor acute lymphoblastic leukemia (B-ALL). For the treatment of adult patients with relapsed/refractory mantle cell lymphoma (r/r MCL).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/gFWBVZ8

April 25, 2024 at 11:01PM YESCARTA

For the treatment of adult patients with large B-cell lymphoma that is refractory to first-line chemoimmunotherapy or that relapses within 12 months of first-line chemoimmunotherapy. Axicabtagene ciloleucel is not indicated for the treatment of patients with primary central nervous system lymphoma.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/uKlsTjN

April 25, 2024 at 07:50PM Combating Antibiotic Resistance

Misuse and overuse of antibiotics have contributed to antibiotic resistance, a phenomenon that reduces or eliminates the effectiveness of antibiotics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/fsVZwlU

April 25, 2024 at 06:07PM Clinical Guidances

This page lists Clinical Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/fiy0TkQ

Wednesday, April 24, 2024

April 24, 2024 at 05:08PM FDA CBER Webinar: Considerations for the Development of CAR T Cell Products - 03/07/2024

The FDA Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting a virtual public webinar on Thursday, March 7 at 1:00 p.m.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/m3pk5fy

April 24, 2024 at 04:08PM Recently Issued Guidance Documents

This page lists Recently Issued CBER and Cross-Center Guidance Documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/eCdla5M

April 24, 2024 at 04:03PM Labeling and Promotion Guidances

This page lists Labeling and Promotion Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/jArFc6O

Tuesday, April 23, 2024

April 23, 2024 at 07:17PM Health Fraud Scams

Learn how to spot health fraud and avoid it.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/EG7PrWA

April 23, 2024 at 05:12PM eSubmitter Application History

History of all updates to the application software in reverse chronological order by version number

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/hNH4yKJ

April 23, 2024 at 03:14PM Reflections on Travel to Europe – Part Three

I recently had the privilege of official travel to the European Union with our global affairs team.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/a9KGkZ7

Monday, April 22, 2024

April 22, 2024 at 03:09PM Safety, Efficacy, and Pharmacokinetic Studies to Support Marketing of Immune Globulin Intravenous (Human) as Replacement Therapy for Primary Humoral Immunodeficiency

Safety, Efficacy, and Pharmacokinetic Studies to Support Marketing of Immune Globulin Intravenous (Human) as Replacement Therapy for Primary Humoral Immunodeficiency

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/QNKoR7e

April 22, 2024 at 03:03PM “Lookback” for Hepatitis C Virus (HCV): Product Quarantine, Consignee Notification, Further Testing, Product Disposition, and Notification of Transfusion Recipients Based on Donor Test Results Indicating Infection with HCV

Multiple layers of safeguards, including donor screening and testing, are used to reduce the riskof transmitting infection through blood transfusion.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ukgnW3v

April 22, 2024 at 02:29PM Source Animal, Product, Preclinical, and Clinical Issues Concerning the Use of Xenotransplantation Products in Humans

Source Animal Product Preclinical, Clinical Issues, Xenotransplantation Products in Humans, Guidance for Industry, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/cI6PZgr

Friday, April 19, 2024

April 19, 2024 at 10:19PM FDA Roundup: April 19, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/7QW6D9Y

April 19, 2024 at 09:05PM Clinical Investigator Status (Biologics)

Clinical Investigator Inspection List from inspections of clinical investigators who have conducted studies with investigational new drugs or investigational devices reviewed by CBER

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/MKuyn3j

April 19, 2024 at 04:42PM Octaplas

Product approval information is indicated for Replacement of multiple coagulation factors in patients with acquired deficiencies
o due to liver disease
o undergoing cardiac surgery or liver transplant
Plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Zdq0snX

April 19, 2024 at 04:19PM Providing Lot Release Protocol Submissions to the Center for Biologics Evaluation and Research (CBER) in Electronic Format

This is the Guidance for Industry, Providing Lot Release Protocol Submissions to the Center for Biologics Evaluation and Research (CBER) in Electronic Format, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/QYwi7tV

Thursday, April 18, 2024

April 18, 2024 at 05:44PM OTP Events, Meetings, and Workshops

Office of Therapeutic Products Events, Meetings, and Workshops

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/EoXsI7T

April 18, 2024 at 05:44PM OTP Town Hall: CMC Readiness for Gene Therapy BLAs - 06/04/2024

The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting its next virtual town hall on Tuesday, June 4, 2024, to answer stakeholder questions regarding the chemistry, manufacturing, and controls (CMC) information submitted with biologics license applications (BLAs) for gene therapy products. Expe

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/sDXktI4

April 18, 2024 at 02:45PM Notifying FDA of Fatalities Related to Blood Collection or Transfusion

Notifying FDA of Fatalities Related to Blood Collection or Transfusion, CBER, biologics, guidance, industry, blood, transfusion, fatality, safety

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/VW5o37m

Wednesday, April 17, 2024

April 17, 2024 at 04:49PM Patient Listening Session Summaries

Patient Listening Session summaries are published after each session to share a high-level summary of the discussion. The Office of Patient Affairs draft summaries for FDA-requested sessions and the patient community requester drafts summaries for Patient-led sessions.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/wgDdIyM

Tuesday, April 16, 2024

April 16, 2024 at 11:22PM ABECMA (idecabtagene vicleucel)

ABECMA is the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapies including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/VN6zFbn

April 16, 2024 at 08:46PM Drugs@FDA Data Files

Drugs@FDA Downloadable Data File in ZIP format, Data Definitions, and Entity Relationship Diagram (ERD)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/1HbOmMX

April 16, 2024 at 04:10PM Questions and Answers Regarding the End of the Compliance and Enforcement Policy for Certain Human Cells, Tissues, or Cellular or Tissue-based Products (HCT/Ps)

This is the CBER HCT/Ps Q&As- End of Compliance and Enforcement Policy main page with information for health care providers, clinics and regulated industry need to know about the end of FDA's compliance and enforcement policy, which ended on May 31, 2021 if they offer certain HCT/Ps.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/XdJBEw1

April 16, 2024 at 03:36PM Roster of the Blood Products Advisory Committee

This is the Roster of the Blood Products Advisory Committee (BPAC).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/xRtc7fZ

Monday, April 15, 2024

April 15, 2024 at 05:09PM Reflections on Travel to Europe – Part One

I recently had the privilege of official travel to the U.K. and European Union with our global affairs team.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/inNtsFq

April 15, 2024 at 05:00PM General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry

This guidance is intended to assist sponsors of investigational new drug applications (INDs) and applicants of new drug applications (NDAs), biologics license applications (BLAs), and supplements to such applications who are planning to conduct clinical studies in neonatal populations.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/05AcFuh

Thursday, April 11, 2024

April 12, 2024 at 02:16AM Statement on data accuracy issues with recently approved gene therapy

Statement by Peter Marks, M.D., Ph.D., director of FDA’s Center for Biologics Evaluation and Research, on data accuracy issues with recently approved gene therapy

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/nprEaXc

April 12, 2024 at 12:28AM Biologics Electronic Reading Room (eFOIA)

The Biologics eFOI Reading Room provides access to documents posted throughout the "Vaccines, Blood & Biologics" and other sections related to the Center for Biologics Evaluation and Research on the FDA.gov Web site.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/M6c8H3f

April 11, 2024 at 03:28PM Development of Anti-Infective Drug Products for the Pediatric Population

Pediatric Drug Products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/8mzWko5

Wednesday, April 10, 2024

April 11, 2024 at 12:09AM CBER 2024 Orphan Approvals (new BLAs)

CBER 2024 Orphan Approvals

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/BCMDiHO

April 10, 2024 at 05:48PM eSubmitter Application History

History of all updates to the application software in reverse chronological order by version number

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/FtfhTI0

April 10, 2024 at 02:35PM Vaccines and Related Biological Products Advisory Committee May 16, 2024 Meeting Announcement - 05/16/2024

This is the main page for the Vaccines and Related Biological Products Advisory Committee (VRBPAC) May 16, 2024 Meeting announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/RgwcYa3

Tuesday, April 9, 2024

April 09, 2024 at 09:30PM FDA Roundup: April 9, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/DdrFRqw

April 08, 2024 at 03:03PM Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products

This the Guidance for Industry, Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products, Level 1, CBER, CDER, Biologics, Drugs, December 2020

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/FLdUoMH

April 05, 2024 at 05:10PM Vaccines Protect Children From Harmful Infectious Diseases

If you have questions about vaccines, visit the FDA’s guide for parents and caregivers. It describes the routinely administered vaccines for children and provides answers to commonly asked questions.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/4FzMjrL

Monday, April 8, 2024

April 09, 2024 at 12:20AM FDA CBER Webinar: Human Gene Therapy Products Incorporating Human Genome Editing - 02/29/2024

The FDA Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting a virtual public webinar on Thursday, February 29 at 1:00 pm.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/HKshqlL

April 08, 2024 at 05:34PM Providing Information about Pediatric Uses of Medical Devices

This guidance document describes how to compile and submit the readily available pediatric use information required under Section 515A of the FD&C Act.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/TQmFIYw

April 08, 2024 at 05:33PM Leveraging Existing Clinical Data for Extrapolation to Pediatric Uses of Medical Devices

Leveraging Existing Clinical Data for Extrapolation to Pediatric Uses of Medical Devices - Guidance for Industry and Food and Drug Administration Staff

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/8sOQSRx

Friday, April 5, 2024

April 05, 2024 at 10:58PM Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products

Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/w5TPEDl

April 03, 2024 at 09:34PM Use of Whole Slide Imaging in Nonclinical Toxicology Studies: Questions and Answers

Pharmacology/Toxicology

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/FW5XkMe

April 05, 2024 at 08:51PM FDA Roundup: April 5, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/hLcqJru

April 05, 2024 at 04:37PM Beware of Fraudulent Coronavirus Tests, Vaccines and Treatments

Fraudulent products that claim to cure, treat, or prevent COVID-19 haven’t been evaluated by the FDA for safety and effectiveness and might be dangerous to you and your family.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/uPjMg1K

April 05, 2024 at 02:23PM Multilingual COVID-19 Resources

The U.S. Centers for Disease Control and Prevention (CDC), and international and U.S. Government partners including FDA, are addressing an outbreak of coronavirus disease 2019 (COVID-19).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/lEghUM2

April 03, 2024 at 01:14AM Vaccines, Blood & Biologics

From blood to vaccines, FDA protects and advances the public health by ensuring that biological products are safe, effective, and available to those who need them. Read these Consumer Updates to learn more.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/k8bGY4L

April 03, 2024 at 01:03AM FDA Warns About Stem Cell Therapies

Stem cells have been called everything from cure-alls to miracle treatments. But don't believe the hype. The U.S. Food and Drug Administration is concerned that some patients may be vulnerable to stem cell treatments that are illegal and potentially harmful. Here's what to know before you consider s

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/dvTcjK1

Monday, April 1, 2024

April 01, 2024 at 11:48PM Biologics Electronic Reading Room (eFOIA)

The Biologics eFOI Reading Room provides access to documents posted throughout the "Vaccines, Blood & Biologics" and other sections related to the Center for Biologics Evaluation and Research on the FDA.gov Web site.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Bmrzxcf

April 01, 2024 at 05:02PM FDALabel: Full-Text Search of Drug Product Labeling

FDALabel Database is a web-based application that allows users to perform customizable searches of a database containing over 140,000 labeling documents for FDA-approved drug products, including human and animal prescription and over-the-counter drugs, biological products, and medical devices.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Smo8YQ7

April 01, 2024 at 04:47PM Study Data Technical Conformance Guide - Technical Specifications Document

This technical specifications document represents the Food and Drug Administration's (FDA's) current thinking on this topic.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/yiXwoaj

March 29, 2024 at 02:04PM Roster of the Allergenic Products Advisory Committee

As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/imLcWGI

April 01, 2024 at 07:48AM MedWatch: The FDA Safety Information and Adverse Event Reporting Program

MedWatch is made up of voluntary and mandatory reporting on prescription medicines, over-the-counter medicines, non-vaccine biologicals, medical devices, special nutritional products, cosmetics and non-prescription human drug products marketed without an approved application.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2HwbCFR